AcelRx Pharmaceuticals: 3Q Earnings Snapshot

November 6, 2019

REDWOOD CITY, Calif. (AP) _ AcelRx Pharmaceuticals Inc. (ACRX) on Wednesday reported a loss of $12.7 million in its third quarter.

The Redwood City, California-based company said it had a loss of 16 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

The drugmaker posted revenue of $608,000 in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $1.2 million.

In the final minutes of trading on Wednesday, the company’s shares hit $1.91. A year ago, they were trading at $3.90.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRX at https://www.zacks.com/ap/ACRX